Filtered By:
Condition: Cough
Vaccination: Influenza Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 124 results found since Jan 2013.

Healthcare personnel in 2016-2019 prospective cohort infrequently got vaccinated, worked while ill, and frequently used antibiotics rather than antivirals against viral influenza illnesses
Influenza Other Respir Viruses. 2023 Sep 7;17(9):e13189. doi: 10.1111/irv.13189. eCollection 2023 Sep.ABSTRACTBACKGROUND: Uncertainty about risk of illness and the value of influenza vaccines negatively affects vaccine uptake among persons targeted for influenza vaccination.METHODS: During 2016-2019, we followed a cohort of healthcare personnel (HCP) targeted for free-of-charge influenza vaccination in five Lima hospitals to quantify risk of influenza, workplace presenteeism (coming to work despite illness), and absenteeism (taking time off from work because of illness). The HCP who developed acute respiratory illnesses (A...
Source: Respiratory Care - September 11, 2023 Category: Respiratory Medicine Authors: Eduardo Azziz-Baumgartner Joan Neyra Tat S Yau Giselle Soto Daniel Owusu Chao Zhang Candice Romero Young M Yoo Miriam Gonzales Yeny Tinoco Mar ía Silva Eduar Bravo Nancy Rojas Serrano Eduardo Matos Victor Chavez-Perez Juan Carlos Castro Maria Esther Cast Source Type: research

Safety signal identification for COVID-19 bivalent booster vaccination using tree-based scan statistics in the Vaccine Safety Datalink
CONCLUSIONS: For Pfizer-BioNTech only, we detected clusters of: (1) unspecified adverse effects, as have been observed in other vaccine studies using this method, and (2) respiratory disease toward the end of follow-up. The respiratory clusters were likely due to overlap of follow-up with the spread of respiratory syncytial virus, influenza, and COVID-19, i.e., confounding by seasonality. The untargeted nature of the method and its inherent adjustment for the many diagnoses and risk intervals evaluated are unique advantages. Limitations include susceptibility to time-varying confounding, lower statistical power for assessi...
Source: Vaccine - July 21, 2023 Category: Allergy & Immunology Authors: W Katherine Yih Matthew F Daley Jonathan Duffy Bruce Fireman David L McClure Jennifer C Nelson Lei Qian Ning Smith Gabriela Vazquez-Benitez Eric Weintraub Joshua T B Williams Stanley Xu Judith C Maro Source Type: research

Effect of COVID-19 vaccination on influenza-associated respiratory infection (IARI): benefit or backfire
CONCLUSIONS: It has been challenging to reach any definitive conclusions regarding the effects of C19V on IARI, conducting extensive, substantial population-based studies that integrate clinical and virological data from more than one season is absolutely required, despite the fact that the majority of the reported effects were mild and temporary.PMID:37140325 | DOI:10.26355/eurrev_202304_32175
Source: Pharmacological Reviews - May 4, 2023 Category: Drugs & Pharmacology Authors: P Premalatha H A Shadia M H Abuadas F A Zainab B Prema M A Mervat V Krishnaraju P Kousalya N Harikrishnan M Kandasamy S Pranave Source Type: research

Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022
CONCLUSIONS: In this adult population, three mRNA COVID-19 vaccine doses provided substantial protection against symptomatic illness in outpatient settings when the Omicron variant became the predominant cause of COVID-19 in the United States. These findings support the recommendation for a third mRNA COVID-19 vaccine dose.PMID:36825251 | PMC:PMC9353375 | DOI:10.1111/irv.13029
Source: Respiratory Care - February 24, 2023 Category: Respiratory Medicine Authors: Sara S Kim Jessie R Chung H Keipp Talbot Carlos G Grijalva Karen J Wernli Erika Kiniry Emily T Martin Arnold S Monto Edward A Belongia Huong Q McLean Manjusha Gaglani Mufaddal Mamawala Mary Patricia Nowalk Krissy Moehling Geffel Sara Y Tartof Ana Florea J Source Type: research

Pertussis epidemiology in Canada, 2005-2019
CONCLUSION: The highest morbidity and fatality of pertussis were among infants under one year of age. It is important to take measures to reduce transmission to infants who are too young to be vaccinated. Increasing vaccine coverage in children and pregnant women are important to reduce the burden of disease.PMID:36815868 | PMC:PMC9902035 | DOI:10.14745/ccdr.v49i01a05
Source: Can Commun Dis Rep - February 23, 2023 Category: Infectious Diseases Authors: Disha Bhagat Myriam Saboui Grace Huang Francesca Reyes Domingo Susan G Squires Marina I Salvadori Y Anita Li Source Type: research